Open Access813 Incidence and Indicators of Suboptimal Response to Tumor Necrosis Factor Antagonist Therapy in Inflammatory Bowel Disease in Newly Industrialized Countries: Results From the EXPLORE Study
Author(s) -
Othman Al Harbi,
Alessandro Armuzzi,
Webber Chan,
Enrique Ponce de León,
Jiaming Qian,
Marina Shapina,
Murat Törüner,
ChiaHung Tu,
Byong Duk Ye,
Morgane Guennec,
Cecilia Sison,
Dirk Demuth,
Olga Fadeeva,
Rana Qasim Khan,
Jesús K. YamamotoFurusho
Publication year - 2019
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000592788.27677.ec
Subject(s) - medicine , discontinuation , incidence (geometry) , inflammatory bowel disease , ulcerative colitis , gastroenterology , disease , tumor necrosis factor alpha , cumulative incidence , infliximab , crohn's disease , surgery , cohort , physics , optics